At present, most of the samples can be obtained through endoscopic gastric biopsy, but the unobvious cancerous tissue and low levels of HER2 expression in early stage of GC (stage 1–2) leads to a wrong diagnosis. Here, ERBB2 is linked to gastric cancer.